Insurers Are Pocketing Copay Assistance Funds Meant to Curb Patient Drug Costs

AI justification

Federal inaction enables systemic exploitation of patient funds, increasing healthcare inequity. | Federal inaction on copay accumulator programs allows insurers to exploit patient assistance funds, increasing financial barriers to essential medications and violating healthcare access rights. State-level bans demonstrate a positive trajectory toward protecting patients, but the lack of federal oversight creates systemic harm with significant magnitude.